Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 2 1Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3

Conditions

Leukemia, Myeloid, Acute 81Leukemia 33Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Myelodysplastic Syndromes 22Recurrence 13Congenital Abnormalities 12Lymphoma, Non-Hodgkin 9Leukemia, Biphenotypic, Acute 9Burkitt Lymphoma 9Lymphoma, Mantle-Cell 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia, Myelomonocytic, Chronic 7Leukemia, Monocytic, Acute 7Hodgkin Disease 7Lymphoma 6Leukemia, Myelomonocytic, Acute 6Leukemia, Megakaryoblastic, Acute 6Leukemia, Erythroblastic, Acute 6Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Myeloproliferative Disorders 4Lymphoma, Follicular 4Lymphoma, B-Cell 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms 3Leukemia, Prolymphocytic 3Leukemia, Myeloid 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hematologic Neoplasms 3Blast Crisis 3

Interventions

fludarabine phosphate 4Peripheral Blood Stem Cell Transplantation 3Cytarabine 3fludarabine 2Tacrolimus 2Rituximab 2Oxaliplatin 2Methotrexate 2Clofarabine 2Busulfan 2Antilymphocyte Serum 2veltuzumab 1thymoglobulin 1pegfilgrastim 1ofatumumab 1merphos 1ethanolamine oleate 1dinaciclib 1carmustine, poliferprosan 20 drug combination 1acalabrutinib 1Whole-Body Irradiation 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Sulfamethoxazole 1Sodium Chloride 1Saline Solution, Hypertonic 1Saline Solution 1Pentetic Acid 1Mycophenolic Acid 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Leukemia, Prolymphocytic × Cytarabine × Clear all
NCT00005803 2020-01-29

Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma

Fred Hutchinson Cancer Center

Phase 1/2 Completed
76 enrolled 11 charts
LymphoidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, T-Cell, Leukemia, Prolymphocytic

NCT00472849 2013-11-26

Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias

M.D. Anderson Cancer Center

Phase 1/2 Completed
92 enrolled 7 charts
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic

NCT00452374 2011-11-02

Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL

M.D. Anderson Cancer Center

Phase 1/2 Completed
48 enrolled 6 charts
LymphoidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡